We conducted a long-term follow-up study between December 2005 and February 2007 on 4 immunocompetent infants, who repeatedly presented with respiratory symptoms, using PCR-based techniques targeting 14 viruses related to acute respiratory tract infection. Of 38 specimens, 30 were collected from symptomatic infants and 8 were collected when respiratory symptoms were absent. Overall, one or more respiratory viruses were detected in 94.7z (36/38) of the specimens. Of the 36 PCR-positive specimens, 77.8z (28/36) were positive for more than one virus. Most of these co-infections were double infections (55.6z or 20/36). Of note, co-infections with 4 and 3 viruses were observed in 3 (8.3z or 3/36) and 5 (13.9z or 5/36) specimens, respectively. Of the 8 specimens collected from the 4 infants when apparent respiratory symptoms were absent, 7 (87.5z) were positive for respiratory viruses. Respiratory viral co-infections were also frequent and found in 5 of the specimens (62.5z). However, apparent correlation between disease severity and co-infection was undetectable due to the limit of the number of cases studied. Taken together, this longitudinal study revealed that respiratory viral co-infections were not infrequent in infants aged 0-2 years, regardless of the presence of respiratory symptoms (62.5-77.8z).
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Advances in nucleic acid-based technology have resulted in rapid and sensitive diagnoses of respiratory infections and the identification of potential human pathogens from clinical specimens (1) . Several viruses are known to cause respiratory infections in humans, including the influenza virus (IFV), respiratory syncytial virus (RSV), parainfluenza virus (PIV) 1-4, human rhinovirus (HRV), enterovirus (EV), and human adenovirus (HAdV) (2). In addition, recent studies have shown that the human metapneumovirus (hMPV), human bocavirus (HBoV), and human coronavirus (HCoV) also cause respiratory infections (2, 3) . PCRbased analyses have shown that respiratory viral co-infections are quite frequent; for example, approximately 15z of patients with respiratory symptoms were found to be positive for respiratory viral co-infections in one study (4) . However, the clinical impacts of such co-infections remain poorly understood, partly because most of the previous studies were cross-sectional studies (4) (5) (6) . The significance of respiratory viral co-infections, especially in infants without immunological disorders, could be investigated by assessing various populations over a period of time. In the present study, we addressed the same by monitoring 4 infants (age, 0-2 years) without underlying diseases longitudinally between 2005 and 2007. The presence of 14 respiratory viruses was examined in these infants, regardless of whether they presented with respiratory symptoms. Unexpectedly, respiratory viral co-infections, including quadruple infections, were detected more frequently than expected on the basis of previously reported rates (5, 7, 8) . The clinical significance of these viral co-infections was assessed by examining the correlation between co-infection profiles and clinical symptoms.
Four healthy infants were enrolled in this study, including a newborn female (Pt 1), a 9-month-old female (Pt 2), a 9-month-old male (Pt 3), and a 21-month-old female (Pt 4). All the four infants showed no clinical signs indicative of primary immunodeficiency, as diagnosed by a physician, and attended nursery in the Saiseikai Nakatsu Hospital in Osaka between December 2005 and February 2007. The infants repeatedly presented with respiratory symptoms, including fever (over 37.59 C), cough, wheezing, chest retraction, nasal discharge, and decreases in arterial oxygen saturation during the study period. Appearance of any of these symptoms defined the onset of respiratory disease in this study. In total, 38 nasal aspirates were collected for the diagnosis of respiratory infections using an immunochromatographic test kit, which was employed for the rapid diagnosis of respiratory viral infections during onset and after recovery from the disease for the purpose of infection control in the hospital. The remaining portions of the specimens were used as detailed (Table  1 ). Pt 2, Pt 3, and Pt 4 were vaccinated against IFV in October 2006. RNA and DNA were extracted from the Twelve respiratory RNA viruses were tested using three sets of multiplex RT-PCR, each targeting four viruses: set 1, PIV 1-4; set 2, IFV A, IFV B, RSV, and HMPV; and set 3, HRV/EV, IFV C, HCoV-OC43, and HCoV-229E. The two respiratory DNA viruses, HAdV and HBoV, were examined by conventional PCR. The primers used in this study are listed in Table 2 . The detection limits of the in-house PCR were comparable to those obtained by the methods described previously (9, 10) . HAdV and HBoV were 10 copies/ml, respectively. The amplicons were sequenced using BigDye Terminator Cycle Sequencing Ready Reaction kits (Applied Biosystems, Foster City, CA, USA).
In total, 38 specimens were collected. Of these, eight were collected in the absence of respiratory symptoms. Overall, one or more respiratory viruses were detected in 94.7z (36/38) of the specimens. The most frequently detected virus was HAdV (69.4z or 25/36), followed by HBoV (47.2z or 17/36), HRV (38.9z or 14/36), PIV (22.2z or 8/36), RSV (19.4z or 7/36), HMPV (5.6z or 2/36), EV (2.8z or 1/36), and HCoV-OC43 (2.8z or 1/36). RSV and PIV 2 were detected during the winter season, whereas HBoV, HAdV, and HRV were detected throughout the year. The genomic sequences of all HBoV isolates were identical to a previously reported sequence (accession no. FJ548924). On the other hand, the genomic sequence identities of the HRV isolates ranged from 67.3z to 81.2z, suggesting that each HRV infection was caused by an independent virus. On an average, 2.0 ± 0.9 viruses were detected per sample.
Of the 36 PCR-positive specimens, 77.8z (28/36) were positive for more than one virus. Most of these coinfections were double infections (55.6z or 20/36). Of note, co-infections with four and three viruses were observed in three (8.3z or 3/36) and five (13.9z or 5/36) specimens, respectively. The most frequent double infection occurred with HAdV and HBoV (17.9z or 5/28), followed by HAdV and HRV (14.3z or 4/28).
Seven events requiring hospitalization were reported in the four infants, and five specimens were obtained during hospitalization, when symptoms were present ( Table 1) . Each sample was collected 2-5 days after the onset of disease. Respiratory viruses were detected in all the events, three of which presented with co-infections of HAdV and HRV. An average of 2.0 ± 1.0 viruses was detected per sample.
Eight specimens were collected from the four infants in the absence of apparent respiratory symptoms, six of the specimens were obtained more than 10 days after the onset of disease, while two (P3-8 and P4-2) were obtained 2 and 4 days after onset, respectively. Of note, seven of the eight specimens (87.5z) were positive for respiratory viruses, including HAdV, HBoV, HRV, and PIV. Co-infections were also frequent; they were present in five of the eight specimens (62.5z). The coinfections of HAdV and HRV or HAdV and PIV were common, with each detected in two of the eight specimens (25.0z). Of note, four viruses, HBoV, PIV 2, HRV, and coxsackievirus A9 were detected in the sample P4-2 from patient 4. An average of 2.0 ± 1.4 viruses was detected per sample. IFV and HCoV229-E were not detected in this study.
In the present work, the respiratory viral infection profiles of infants were examined over a period of 15 months. The uniqueness of this study arises from the fact that infants under 2 years of age, who lacked any apparent underlying diseases, were subjected to a longitudinally study. Moreover, specimens were recovered from the infants in the absence of respiratory symptoms. Although some reports suggest a link between multiple infections and increased severity of clinical symptoms (5, 8) , a clear correlation between respiratory viral co-infection and disease severity was not observed in the present study, which is in agreement with a previous report by Paula et al. (11) . The unique clinical manifestations associated with a particular respiratory viral infection or co-infection profile could also not be identified. It may be that respiratory viral co-infections only affect disease severity in specific situations where other factors are involved, either by themselves or in combination; these include underlying diseases, genetic backgrounds, and the involvement of particular bacterial infections.
Three of the four patients received IFV vaccine in October 2006, following which IFV was not detected in this study. Although there are only few opportunities for children in the hospital nursery to come in contact with IFV patients, the lack of IFV detection in this study suggests that the vaccination provided protection against IFV infection.
In this study, HRV was detected in 14 of the 36 specimens, mostly as co-infections (13/14); 10 of these 13 specimens were collected from symptomatic patients. Only HRV was detected in P4-6, corresponding to moderate clinical symptoms (Table 1 ). It has recently been shown that asymptomatic individuals often harbor HRV (12) , and Lauinger et al. also reported that the HRV genotype per se was not linked to the severity of clinical symptoms (13) . Data from the present study also support the notion that HRV infection is common among the human population. HBoV pathogenesis has been a recent subject of contention; a birth cohort longitudinal study of Danish children detected HBoV frequently in both symptomatic and asymptomatic infants (3, 14) . In the present study, the pathogenic potential of HBoV in infants with no underlying diseases was unclear. HBoV was intermittently detected for 3-10 months, but the viral genomic sequences that were detected in each infant were identical, suggesting continued viral shedding rather than re-infection with HBoV. This was also observed previously in immunocompromised children and in patients with prolonged respiratory symptoms lasting several months (3, 7) . It is likely that HBoV establishes a persistent infection in the tonsils (3) without inducing symptoms, such that shedding becomes apparent only when respiratory symptoms are triggered by other viral infections that increase respiratory secretion. It was reported previously that coinfections with HBoV and HAdV are frequent, with HAdV being detected in approximately 30z of HBoVpositive cases (7) , suggesting that these viruses may interact in vivo. For example, HAdV infection may re-activate the persistent HBoV infection. It remains unclear whether HBoV is pathogenic in patients with underlying diseases or in patients infected with other respiratory Respiratory Viral Co-Infections in Infants viruses. These questions will be addressed in future studies involving frequent samplings of aspirates from infants in the presence or absence of symptoms and comparison with serological diagnosis.
To conclude, a clear correlation between viral co-infection and severity of clinical symptoms was not observed in the present study. However, further research is required to evaluate viral co-infection synthetically. In-creases in the size of the study group and frequency of sampling, examination of particular bacterial infections, or a combination of these factors need to be incorporated in future studies.
